Evaluation of VeriStrat, a serum proteomic test, in the randomized, open-label, Phase 3 LUX-Lung 8 trial of afatinib versus erlotinib for the second-line treatment of advanced squamous cell carcinoma of the lung
Makaleler > Tam Makale · 2016
Yazarlar: G. Goss, K.H. Lee, E. Felip, M. Cobo, K. Syrigos, Erdem GÖKER, V. Georgioulias, S.Z. Guclu, D. Isla, Y.J. Min, A. Morabito, N. Dupuis, V.K. Chand, F. Solca, N. Krämer, N. Gibson, E. Ehrnrooth, J.C. Soria
Annals of Oncology, Uluslararası, Wos, 2016, cilt 27, ss vi428-vi428